Bombesin-dependent Pro-MMP-9 activation in prostatic cancer cells requires β1 integrin engagement

Experimental Cell Research

Volumn 280, Issue 1, 2002, Pages 1-11

  Festuccia, Claudio ^a   Angelucci, Adriano ^a   Gravina, Giovanni Luca ^a   Eleuterio, Enrica ^a   Vicentini, Carlo ^a   Bologna, Mauro ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Bombesin; MMP 9; Neupeptides; Prostate cancer; Urokinase; 1 integrin

Indexed keywords

ANTIBODY; BETA1 INTEGRIN; BOMBESIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOCHALASIN D; GELATINASE B; LIGAND; PLASMINOGEN ACTIVATOR; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; TIME; WESTERN BLOTTING;

MAMMALIA;

EID: 0036034543     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5609     Document Type: Article

References (47)

1. di Sant'Agnese, P. A. (1992). Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol. 23, 287-296.
2. Cox, M. E., Deeble, P. D., Lakhani, S., and Parsons, S. J. (1999). Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: Implications for prostate cancer progression. Cancer Res. 59, 3821-3830.
3. Heasley, L. E. (2001). Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 20, 1563-1569.
4. Lee, L. F., Guan, J., Qiu, Y., and Kung, H. J. (2001). Neuropeptide-induced androgen independent prostate cancer cells: Roles of nonreceptor tyrosine kinases etk/bmx, SRC, and focal adhesion kinase. Mol. Cell. Biol. 21, 8385-8397.
5. Bologna, M., Festuccia, C., Muzi, P., Biordi, L., and Ciomei, M. (1989). Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63, 1714-1720.
6. Festuccia, C., Guerra, F., D' Ascenzo, S., Giunciuglio, D., Albini, A., and Bologna, M. (1998). In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer 75, 418-431.
7. Saurin, J. C., Rouault, J. P., Abello, J., Berger, F., Remy, L., and Chayvialle, J. A. (1999). High gastrin releasing peptide receptor mRNA level is related to tumour dedifferentiation and lymphatic vessel invasion in human colon cancer. Eur. J. Cancer 35, 125-132.
8. Stieber, P., Dienemann, H., Schalhorn, A., Schmitt, U. M., Reinmiedl, J., Hofmann, K., and Yamaguchi, K. (1999). Progastrin-releasing peptide (ProGRP)-A useful marker in small cell lung carcinomas. Anticancer Res. 19, 2673-2678.
9. Gugger, M., and Reubi, J. C. (1999). Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Am. J. Pathol. 155, 2067-2076.
10. Salazar, E. P., and Rozengurt, E. (1999). Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J. Biol. Chem. 274, 28371-28378.
11. Nadav, L., and Katz, B. Z. (2001). The molecular effects of oncogenesis on cell-extracellular matrix adhesion (review). Int. J. Oncol. 19, 237-246.
12. Chrenek, M. A, Wong, P., and Weaver, V. M. (2001). Tumourstromal interactions: Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res. 3, 224-229.
13. Li, L., Okura, M., and Imamoto, A. (2002). Focal adhesions require catalytic activity of Src family kinases to mediate integrin-matrix adhesion. Mol. Cell. Biol. 22, 1203-1217.
14. Salazar, E. P., and Rozengurt, E. (1999). Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J. Biol. Chem. 274, 28371-28378.
15. Ingber, D. E. (1997). Integrins, tensegrity, and mechanotransduction. Gravit. Space Biol. Bull. 10, 49-55.
16. Phillips, D. R., Prasad, K. S., Manganello, J., Bao, M., and Nannizzi-Alaimo L. (2001). Integrin tyrosine phosphorylation in platelet signaling. Curr. Opin. Cell Biol. 13, 546-554.
17. Mercurio, A. M., Rabinovitz, I., and Shaw, L. M. (2001). The alpha 6 beta 4 integrin and epithelial cell migration. Curr. Opin. Cell Biol. 13, 541-545.
18. Danen, E. H., and Yamada, K. M. (2001). Fibronectin, integrins, and growth control. J. Cell. Physiol. 189, 1-13.
19. Chrenek, M. A., Wong, P., and Weaver, V. M. (2001). Tumourstromal interactions: Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res. 3, 224-229.
20. Li, S., Kim, M., Hu, Y. L., Jalali, S., Schlaepfer, D. D., Hunter, T., Chien, S., and Shyy J. Y. (1997). Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated protein kinases. J. Biol. Chem. 272, 30455-30462.
21. Kawahara, E., Nakada, N., Hikichi, T., Kobayashi, J., and Nakanishi, I. (2002). EGF and beta1 integrin convergently regulate migration of A431 carcinoma cell through MAP kinase activation. Exp. Cell Res. 272, 84-91.
22. Bonewald, L. F. (1999). Regulation and regulatory activities of transforming growth factor beta. Crit. Rev. Eukaryotic Gene Expression 9, 33-44.
23. Festuccia, C., Bologna, M., Gravina, G. L., Guerra, F., Angelucci, A., Villanova, I., Millimaggi, D., and Teti, A. (1999). Osteoblast conditioned media contain TGF-31 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int. J. Cancer 81, 394-403.
24. Deftos, L. J. (2000). Prostate carcinoma: Production of bioactive factors. Cancer 88, 3002-3008.
25. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996). Localization of matrix metalloproteinase to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683-693.
26. Esparza, J., Vilardell, C., Calvo, J., Juan, M., Vives, J., Urbano-Marquez, A., Yague, J., and Cid M. C. (1999). Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94, 2754-2766.
27. Festuccia, C., Angelucci, A., Gravina, G. L., Villanova, I., Teti, A., Albini, A., and Bologna M. (2000). Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Int. J. Cancer 85, 407-415.
28. Ballin, M., Mackay, A. R., Hartzler, J. L., Nason, A., Pelina, M. D., and Thorgeirsson, U. P. (1991). Ras levels and metallo-proteinase activity in normal versus neoplastic rat mammary tissues. Clin. Exp. Metastasis 9, 179-189.
29. Stearns, M. E., Fudge, K., Garcia, F., and Wang, M. (1997). IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of expression. Invasion Metastasis 17, 62-74.
30. Wood, M., Fudge, K., Mohler, J. L., Frost, A. R., Garcia, F., Wang, M., and Stearns, M. E. (1997). In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis 15, 246-258.
31. Lokeshwar, B. L., Selzer, M. G., Block, N. L., and Gunja-Smith, Z. (1993). Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res. 53, 4493-4498.
32. Festuccia, C., Bologna, M., Vicentini, C., Tacconelli, A., Miano, R., Violini, S., and Mackay, A. R. (1996). Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. Int. J. Cancer 69, 386-393.
33. Festuccia, C., Guerra, F., D' Ascenzo, S., Giunciuglio, D., Albini, A., and Bologna, M. (1998). In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer 75, 418-431.
34. Degryse, B., Orlando, S., Resnati, M., Rabbani, S. A., and Blasi, F. (2001). Urokinase/urokinase receptor and vitronectin/al-pha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene 20, 2032-2043.
35. Biliran, H, Jr., and Sheng, S. (2001). Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res. 61, 8676-8682.
36. Hart, C. A., Scott, L. J., Bagley, S., Bryden, A. A., Clarke, N. W., and Lang, S. H. (2002). Role of proteolytic enzymes in human prostate bone metastasis formation: In vivo and in vitro studies. Br. J. Cancer 86, 1136-1142.
37. Yebra, M., Goretzki, L., Pfeifer, M., and Mueller, B. M. (1999). Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp. Cell. Res. 250, 231-240.
38. Luque, A., Gomez, M., Puzon, W., Takada, Y., Sanchez-Madrid, F., and Cabanas, C. (1996). Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J. Biol. Chem. 271, 11067-11075.
39. Wayner, E. A., Gil, S. G., Murphy, G. F., Wilke, M. S., and Carter, W. G. (1993). Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J. Cell Biol. 121, 1141-1152.
40. Dittel, B. N., McCarthy, J. B., Wayner, E. A., and LeBien, T. W. (1993). Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 81, 2272-2282.
41. Mackay, A. R., Hartzler, J. L., Pelina, M. D., and Thorgeirsson, U. P. (1990). Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. Biol. Chem. 265, 21929-21934.
42. Salazar, E. P. and Rozengurt, E. (2001). Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J. Biol. Chem. 276, 17788-17795.
43. Festuccia, C., Gravina, G. L., Angelucci, A., Millimaggi, D., and Bologna, M. (2000). Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line. Anticancer Res. 20, 4367-4371.
44. Teti, A., Farina, A. R., Villanova, I., Tiberio, A., Tacconelli, A., Sciortino, G., Chambers, A. F., Gulino, A., and Mackay, A. R. (1998). Activation of human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent. Int. J. Cancer. 77, 82-93.
45. Sliva, D., Rizzo, M. T., and English, D. (2002). Phosphatidylinositol 3-kinase and NF-3B regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J. Biol. Chem. 277, 3150-3157.
46. Asano, S., Seishima, M., and Kitajima, Y. (2001). Phosphatidylinositol-specific-phospholipase C cleaves urokinase plasminogen activator receptor from the cell surface and leads to inhibition of pemphigus-IgG-induced acantholysis in DJM-1 cells, a squamous cell carcinoma line. Clin. Exp. Dermatol. 26, 289-295.
47. Plo, I., Lautier, D., Levade, T., Sekouri, H., Jaffrezou, J. P., Laurent, G., and Bettaieb, A. (2000). Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor kappaB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid-leukaemia cells. Biochem. J. 351, 459-467.